Postgraduate Course

Course Directors: Charles J. Kahi, MD, MSc, FACG and Neil H. Stollman, MD, FACG

Attend this year’s Annual Postgraduate Course, “State of the Art and Science in Clinical Gastroenterology” and leave with practical takeaway points that you can implement in practice. Learn better ways to integrate the newest tools in diagnosis with the latest therapeutic/treatment alternatives to achieve optimal outcomes, improve your awareness and ability to incorporate patient care decision-making issues relating to common and not-so-common GI patient conditions, and enhance your overall capacity to frame effective disease management strategies in your practice.

Saturday, October 6, 2018 | 7:50 am - 5:00 pm
7:00 am Registration
7:50 am Introduction by Course Co-Directors
Charles J. Kahi, MD, MSc, FACG and Neil H. Stollman, MD, FACG
8:00 am Session 1A: Functional Disorders
Moderator: Brian E. Lacy, MD, PhD, FACG
  • Pharmacologic Treatment of IBS
    Lin Chang, MD, FACG
    Evaluate the selection of appropriate pharmacologic agents for the treatment of IBS.
  • Non-Pharmacologic Treatment of IBS
    William D. Chey, MD, FACG
    Discuss complementary, alternative, dietary, and psychosocial strategies in the treatment of IBS.
  • Food Allergies, Sensitivities, and Specialty Diets (Beyond Gluten)
    Brian E. Lacy, MD, PhD, FACG
    Explain best current practice in the use of specialty diets in the care of patients with food allergies and sensitivities.
  • Chronic Abdominal Pain and Bloating
    Lawrence R. Schiller, MD, MACG
    Identify diagnostic and management options in the treatment of chronic abdominal pain, bloating, and dyspepsia.
  • Panel Q & A
9:40 am Break
10:00 am The David Sun Lecture – Translational Approaches to Common GI Diseases....
Thinking Out of the Box.....The Future is Now!

David A. Johnson, MD, MACG
Explore diet, prebiotic/microbiome changes, sleep/behavioral, and non-prescription medication use as pathways for optimizing disease management.
10:30 am Session 1B: Hepatology
Moderator: David E. Bernstein, MD, FACG
    David E. Bernstein, MD, FACG
    Review diagnostic and treatment options in NAFLD/NASH.
  • Drug-Induced Liver Injury: Causes and Management
    Raj K. Vuppalanchi, MD
    Describe important causes of drug-induced liver injury and management strategies.
  • Approach to the Liver Mass
    Fasiha Kanwal, MD, MSHS
    Evaluate diagnostic and treatment interventions for patients with liver masses.
  • Viral Hepatitis: Where We Are in 2018
    Paul Y. Kwo, MD, FACG
    Summarize recent advances in the management of HBV and HCV.
  • Panel Q & A
12:10 pm Break for Learning Luncheons
12:20 pm Saturday Optional Learning Luncheons – Choose from 12

(You must register separately for learning lunches during the registration process.)

  1. Post-Operative Care of the Bariatric Surgery Patient: Role of the Gastroenterologist
    Violeta B. Popov, MD, PhD, FACG
    Discuss aspects of post-operative care (nutritional, endoscopic) of the patient after bariatric procedures (routine care and common complications).
  2. Autoimmune Hepatitis
    Mark W. Russo, MD, MPH, FACG
    Explain diagnostic and treatment recommendations for patients with autoimmune hepatitis.
  3. Tough Colons and Tough Polyps: Tips and Tricks
    Tonya R. Kaltenbach, MD, MS, FACG
    Summarize techniques most helpful in difficult colonoscopies and polypectomies.
  4. Approach to the Patient With Refractory Esophageal Symptoms
    Ronnie Fass, MD, FACG
    Explain diagnosis and treatment of functional heartburn and chest pain.
  5. Endoscopy Extremes: Oropharyngeal and Perianal Primer for the Gastroenterologist
    Amy E. Foxx-Orenstein, DO, MACG
    Enumerate clinically relevant oropharyngeal and perianal findings that may be encountered by gastroenterologists.
  6. Management of Rumination, Cyclic Vomiting, and Cannabis Hyperemesis
    Lin Chang, MD, FACG
    Describe diagnostic and treatment plans for patients with rumination and emesis disorders.
  7. Care of the CRC Patient After Diagnosis (Surgery, Chemotherapy, Surveillance)
    Charles J. Kahi, MD, MSc, FACG
    Discuss best practices after the diagnosis of colorectal cancer, with a focus on the role of the gastroenterologist.
  8. SIBO: Testing and Treatment
    Eamonn M.M. Quigley, MD, MACG
    Identify practical testing and management plans for SIBO.
  9. Eosinophilic Disorders of the GI Tract
    Evan S. Dellon, MD, MPH, FACG
    Outline the treatment of eosinophilic esophagitis, and discuss other eosinophilic GI disorders.
  10. Ischemic Bowel Disorders
    Paul Feuerstadt, MD, FACG
    Review new understanding of mesenteric and colon ischemia in light of recent ACG guidelines.
  11. Autoimmune Pancreaticobiliary Disease
    Timothy B. Gardner, MD, MS, FACG
    Discuss the approach to and treatment of autoimmune pancreatitis, PBC, and PSC.
  12. Dyssynergic Defecation and Pelvic Floor Disorders
    Satish S.C. Rao, MD, PhD, FACG
    Describe the evaluation of and interventions for patients with defecatory dysfunction.
1:35 pm Break
1:45 pm Simultaneous Symposia – Choose from 3

Symposium A: HELLP! My GI Patient Is Pregnant…
Moderator: Uma Mahadevan, MD, FACG

  • Endoscopy and Sedation in Pregnancy
    Joseph C. Anderson, MD, MHCDS, FACG
    Evaluate sedation and endoscopy in the pregnant patient.
  • The Pregnant IBD Patient
    Uma Mahadevan, MD, FACG
    Discuss outcomes and interventions in the pregnant IBD patient.
  • Liver Disorders in Pregnancy
    Nancy S. Reau, MD, FACG
    Identify important hepatic disorders in pregnancy.
  • Panel Q & A

Symposium B: GI Bleeding
Moderator: John R. Saltzman, MD, FACG

  • Non-Variceal GI Bleeding: Prevention and Treatment
    John R. Saltzman, MD, FACG
    Explain prevention and treatment of non-variceal GI bleeding.
  • Variceal GI Bleeding: Prevention and Treatment
    Robert J. Wong, MD, FACG
    Review prevention and treatment of variceal hemorrhage.
  • Obscure GIB: Imaging and Interventions
    Jonathan A. Leighton, MD, FACG
    Describe algorithms and advice for identifying the causes of obscure GI bleeding and possible interventions.
  • Panel Q & A

Symposium C: Bugs N’ Guts
Moderator: Christina M. Surawicz, MD, MACG

  • Enteric Infections: The Usual Suspects and Beyond
    Christina M. Surawicz, MD, MACG
    Identify diagnostic testing advances and treatments of patients with enteric infections.
  • Clostridium difficile: Are We Making Progress?
    Jessica R. Allegretti, MD, MPH
    Evaluate recent pharmacologic, immunologic, and bacteriotherapy advances in the treatment of C. difficile.
  • Helicobacter pylori
    David A. Greenwald, MD, FACG
    Discuss state-of-the-art management approaches to H. pylori in light of recent ACG guidelines.
  • Panel Q & A
3:00 pm Break
3:20 pm Session 1C: Pancreatobiliary
Moderator: Timothy B. Gardner, MD, MS, FACG
  • Prevention and Treatment of Acute Pancreatitis
    Timothy B. Gardner, MD, MS, FACG
    Explain how best to prevent post-ERCP pancreatitis and treat patients with acute pancreatitis.
  • Medical, Endoscopic, and Surgical Approaches to Chronic Pancreatitis
    Douglas G. Adler, MD, FACG
    Summarize possible medical, endoscopic, and surgical approaches to chronic pancreatitis.
  • Cystic Neoplasms of the Pancreas
    Mohammad Al-Haddad, MD, FACG
    Describe diagnostic and treatment recommendations for pancreatic cysts.
  • Panel Q & A
4:40 pm Take-home Pearls: What Did We Learn Today?
Charles J. Kahi, MD, MSc, FACG, and Neil H. Stollman, MD, FACG
Review important and practical take-home messages from today’s talks.
5:00 pm Adjourn for the day